MargaretO'DonnellMD

PubMed

• Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment
  Julie A. Wolfson, Joshua S. Richman, Can-Lan Sun, Wendy Landier, Karen Leung, Eileen Smith, Margaret R. O'Donnell, Smita Bhatia> ;Cancer Epidemiology, Biomarkers & Prevention. 2018 Oct 1
• Use of the Internet for long-term clinical follow-up.
  Aucar, J. A., Doarn, C. R., Sargsyan, A., Samuelson, D. A., Odonnell, M. J., DeBakey, M. E.> ;Telemed J. 1998

Abstracts/Posters

• SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemi...
  Margaret R O'Donnell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Cytokine Gene Polymorphisms Are Associated with Disease Response to Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Clinical Outcomes of MDS Patients Who Were Allogeneic Hematopoietic Stem Cell Transplant Candidates but Did Not Proceed with Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• MIPSS70+ V2.0 and Revised Cytogenetics Changes Predict Outcomes of Allogeneic Transplantation with Fludarabine and Melphalan Conditioning in Patients with Myelofibrosis 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018